SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-198369
Filing Date
2015-05-22
Accepted
2015-05-22 13:36:53
Documents
7
Period of Report
2015-05-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d932328d8k.htm 8-K 22111
2 EX-1.1 d932328dex11.htm EX-1.1 216011
3 EXHIBIT 5.1 d932328dex51.htm EX-5.1 13857
4 EX-99.1 d932328dex991.htm EX-99.1 6861
5 GRAPHIC g932328g82c90.jpg GRAPHIC 9338
6 GRAPHIC g932328img1.jpg GRAPHIC 8639
7 GRAPHIC g932328img2.jpg GRAPHIC 7209
  Complete submission text file 0001193125-15-198369.txt   295108
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36281 | Film No.: 15885838
SIC: 2834 Pharmaceutical Preparations